Percutaneous aortic valve implantation: Present and future. Controlled clinical application before the results of randomised trials

Hellenic Journal of Cardiology

Volumn 50, Issue 4, 2009, Pages 237-244

  Spargias, Konstantinos ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Aortic valve stenosis; Percutaneous valve implantation; Prosthetic aortic valve

Indexed keywords

AGED; AORTA VALVE; AORTA VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; EDITORIAL; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; MALE; MORBIDITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SURGICAL MORTALITY; SURGICAL RISK; TRANSLUMINAL VALVULOPLASTY;

AGED; AORTIC VALVE; CONTROLLED CLINICAL TRIALS AS TOPIC; HEART CATHETERIZATION; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 67749147517     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (37)

1. Cribier A, Letac B. Percutaneous balloon aortic valvuloplasty in adults with calcific aortic stenosis. Curr Opin Cardiol. 1991; 6: 212-218.
2. Abdul-Hamid AR, Mulley GP. Why do so few older people with aortic stenosis have valve replacement surgery? Age Ageing. 1999; 28: 261-264.
3. Bouma BJ, van den Brink RBA, van der Meulen JHP, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999; 82: 143-148.
4. Thomas M, Schymik G, Walther T, et al; on behalf of the SOURCE Investigators. 30 day results of the SOURCE registry. EuroPCR, May 19-22, 2009, Barcelona, Spain.
5. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving system: results from multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv. 2008; 4: 242-249.
6. Spargias K, Manginas A, Pavlides G, et al. Transcatheter aortic valve implantation. First Greek experience. Hellenic J Cardiol. 2008; 49: 397-407.
7. Task Force. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Circulation. 2006; 114: 84-231.
8. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986; 1: 63-67.
9. NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results from the NHLBI balloon valvuloplasty registry. Circulation. 1991; 84: 2383-2397.
10. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation. 1994; 89: 642-650.
11. Sprigings DC, Jackson G, Chambers JB, et al. Balloon dilatation of the aortic valve for inoperable aortic stenosis. BMJ. 1988; 297: 1007-1111.
12. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve longterm survival. J Am Coll Cardiol. 1995; 26: 1522-1528.
13. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24: 1231-1243.
14. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. 2006; 15: 312-321.
15. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005; 111: 3290-3295.
16. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves: description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992; 13: 704-708.
17. Cribier A, Eltchaninoff H, Bash A, et al. Trans-catheter implantation of balloon-expandable prosthetic heart valves: early results in an animal model. Circulation. 2001;104 (Suppl II): I-552.
18. Sochman J, Peregrin JH, Pavcnik D, Timmermans H, Rosch J. Percutaneous transcatheter aortic disc valve prosthesis implantation: a feasibility study. Cardiovasc Intervent Radiol. 2000; 23: 384-388.
19. Lutter G, Kuklinski D, Berg G, et al. Percutaneous aortic valve replacement: an experimental study. J Thorac Cardiovasc Surg. 2002; 123: 768-776.
20. Fuster V, Goldbarg SH, Hansalia RJ, Stevens GR, Tiyyagura SR. The inoperable valvular heart disease patient: the pluses and minuses of percutaneous valvular replacement. EuroInterv. 2006; 2: 154-160.
21. Roques F, Nashef SA, Michel P; for the EuroSCORE Study Group. Risk factors for early mortality after valve surgery in Europe in the 1990's: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001; 10: 572-578.
22. Stewart AS, Smith CR. Transcatheter aortic valve replacement: a surgeon's perspective. EuroInterv. 2007; 3: 25-27.
23. Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J. 2009; 30: 74-80.
24. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008; 135: 180-187.
25. Descoutures F, Himbert D, Lepage L, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J. 2008; 29: 1410-1417.
26. Otten AM, van Domburg RT, van Gameren M, et al. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroInterv. 2008; 4: 250-255.
27. Dobrin PB. Mechanical properties of arteries. Physiol Reviews. 1978; 58: 397-460.
28. Moss RR, Ivens E, Pasupati S, et al. Role of echocardiography in percutaneous aortic valve replacement. JACC Cardiovasc Imaging. 2008; 1: 15-24.
29. Babaliaros VC, Liff D, Chen EP, et al. Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? JACC Interv. 2008; 1: 580-586.
30. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008; 29: 1463-1470.
31. Serruys PW, Piazza N, de Jaegere P. Results of transfemoral aortic valve implantation. EuroPCR, May 19-22, 2009, Barcelona, Spain.
32. Buellesfeld L. 12 months safety and performance results of transcatheter aortic valve implantation using the 18F Core Valve Revalving prosthesis. EuroPCR, May 19-22, 2009, Barcelona, Spain.
33. Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg. 2008; 85: 108-112.
34. Grossi EA, Schwartz CF, Yu P-Y, et al. High-risk aortic valve replacement. Are the outcomes as bad as predicted? Ann Thorac Surg. 2008; 85: 102-107.
35. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007; 116: 755-763.
36. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg. 2009; 87: 276-283.
37. Roberts WC, Ko JM, Hamilton C. Comparison of valve structure, valve weight, and severity of the valve obstruction in 1849 patients having isolated aortic valve replacement for aortic valve stenosis (with or without associated aortic regurgitation) studied at 3 different medical centers in 2 different time periods. Circulation. 2005; 112: 3919-3929.